HC
Highbridge Capital Management LLC cut its INMB stake below 5%
Highbridge Capital Management LLC reported owning 5% of Inmune Bio, Inc. (INMB) (1,454,400 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.